SC
WVE icon

Stempoint Capital’s Wave Life Sciences WVE Stock Holding History

Stempoint Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,110,152
Closed -$15.4M – 115
2025
Q3 		$15.4M Buy
2,110,152
+1,209,814
+134% +$9.79M 3.09% 8
2025
Q2 		$5.85M Buy
900,338
+810,505
+902% +$5.35M 1.88% 21
2025
Q1 		$726K Sell
89,833
-631,376
-88% -$6.9M 0.23% 49
2024
Q4 		$8.92M Buy
721,209
+421,209
+140% +$5.62M 2.23% 15
2024
Q3 		$2.46M Buy
+300,000
New +$1.79M 0.74% 33

Other funds holding WVE

GP
GSK plc London $599M AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return